Benzyl (trans-4-(aminomethyl)cyclohexyl)carbamate

Catalog No. :
ACJDNG469
CAS No. :
177582-74-0
Molecular Formula :
C15H22N2O2
Molecular Weight :
262.35

IUPAC Name:benzyl ((1r,4r)-4-(aminomethyl)cyclohexyl)carbamate

Benzyl (trans-4-(aminomethyl)cyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$195.00Login to see priceInquiryInquiry
250mg95%$371.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl (trans-4-(aminomethyl)cyclohexyl)carbamate
IUPAC Namebenzyl ((1r,4r)-4-(aminomethyl)cyclohexyl)carbamate
MDL No.MFCD06657669
Molecular FormulaC15H22N2O2
Molecular Weight262.35
SMILESO=C(OCC1=CC=CC=C1)N[C@H]2CC[C@H](CN)CC2
InChI KeyAJYOPGOCTHCBTL-MQMHXKEQSA-N
Synonym177582-74-0 | BENZYL TRANS-4-AMINOMETHYLCYCLOHEXYLCARBAMATE | Benzyl (trans-4-(aminomethyl)cyclohexyl)carbamate | C15H22N2O2 | benzyl N-[4-(aminomethyl)cyclohexyl]carbamate | Trans-(4-aminomethyl-cyclohexyl)-carbamic acid benzyl ester | Benzyl (4-(aminomethyl)cyclohe
CAS No.177582-74-0
PubChem CID22253963

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACJDNG469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJDNG469 route product structure diagram
    ACJDNG469177582-74-0
Inquiry

2. ACJDNG469 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2 In Stock
  6. Then
  7. ACJDNG469 route product structure diagram
    ACJDNG469177582-74-0
Inquiry

Comments (0)